Iofina (LON:IOF - Get Free Report) was upgraded by research analysts at Canaccord Genuity Group to a "buy" rating in a research note issued to investors on Thursday,London Stock Exchange reports. The firm presently has a GBX 60 price objective on the stock, up from their prior price objective of GBX 45. Canaccord Genuity Group's price target would indicate a potential upside of 53.85% from the stock's current price.
Iofina Stock Up 20.0%
Shares of IOF traded up GBX 6.50 on Thursday, reaching GBX 39. The stock had a trading volume of 4,079,779 shares, compared to its average volume of 612,622. The company has a 50-day simple moving average of GBX 26.84 and a 200-day simple moving average of GBX 25.21. The firm has a market capitalization of £74.82 million, a price-to-earnings ratio of 15.60 and a beta of 0.53. Iofina has a 12-month low of GBX 20 and a 12-month high of GBX 39.55. The company has a debt-to-equity ratio of 14.85, a quick ratio of 1.56 and a current ratio of 2.43.
Iofina (LON:IOF - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported GBX 4.10 earnings per share (EPS) for the quarter. The business had revenue of GBX 6,651 million during the quarter. Iofina had a return on equity of 9.82% and a net margin of 8.36%. Sell-side analysts predict that Iofina will post 1.8160377 EPS for the current year.
Iofina Company Profile
(
Get Free Report)
Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Iofina, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Iofina wasn't on the list.
While Iofina currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
